Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe.

Campone, Mario

Cost of adverse events during treatment with everolimus plus exemestane or single-agent chemotherapy in patients with advanced breast cancer in Western Europe. [electronic resource] - Journal of medical economics Dec 2014 - 837-45 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1941-837X

10.3111/13696998.2014.959589 doi


Androstadienes--administration & dosage
Antineoplastic Agents--administration & dosage
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Breast Neoplasms--drug therapy
Databases, Factual
Europe
Everolimus
Female
Humans
Models, Economic
Sirolimus--administration & dosage